These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Novel considerations in the pathogenesis of the antiphospholipid syndrome: involvement of the tissue factor pathway of blood coagulation. Adams M Semin Thromb Hemost; 2008 Apr; 34(3):251-5. PubMed ID: 18720304 [TBL] [Abstract][Full Text] [Related]
7. Mechanisms of action of antiphospholipid antibodies in the antiphospholipid syndrome. Aron AL; Gharavi AE; Shoenfeld Y Int Arch Allergy Immunol; 1995 Jan; 106(1):8-12. PubMed ID: 7812170 [TBL] [Abstract][Full Text] [Related]
8. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome. Arnout J Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685 [TBL] [Abstract][Full Text] [Related]
9. Antiphospholipid antibodies in medical practice: a review. Olayemi E; Halim NK Niger J Med; 2006; 15(1):7-15. PubMed ID: 16649444 [TBL] [Abstract][Full Text] [Related]
10. The annexin A5-mediated pathogenic mechanism in the antiphospholipid syndrome: role in pregnancy losses and thrombosis. Rand JH; Wu XX; Quinn AS; Taatjes DJ Lupus; 2010 Apr; 19(4):460-9. PubMed ID: 20353989 [TBL] [Abstract][Full Text] [Related]
11. Antiphospholipid antibodies: specificity and pathophysiology. de Groot PG; Oosting JD; Derksen RH Baillieres Clin Haematol; 1993 Sep; 6(3):691-709. PubMed ID: 8025348 [TBL] [Abstract][Full Text] [Related]
12. Antiphospholipid antibody-mediated disruption of the annexin-V antithrombotic shield: a thrombogenic mechanism for the antiphospholipid syndrome. Rand JH J Autoimmun; 2000 Sep; 15(2):107-11. PubMed ID: 10968894 [TBL] [Abstract][Full Text] [Related]
13. Platelets and the antiphospholipid syndrome. Urbanus RT; Derksen RH; de Groot PG Lupus; 2008 Oct; 17(10):888-94. PubMed ID: 18827053 [TBL] [Abstract][Full Text] [Related]
14. Antiphospholipid antibody syndrome and fetal outcome. Djelmis J; Radoncić E; Ivanisević M Acta Med Croatica; 2001; 55(3):123-30. PubMed ID: 11852731 [TBL] [Abstract][Full Text] [Related]
16. [Primary antiphospholipid syndrome: clinical and biological study of 36 cases]. Vivancos J; López-Soto A; Font J; Balasch J; Cervera R; Reverter JC; Carmona F; Ingelmo M Med Clin (Barc); 1994 Apr; 102(15):561-5. PubMed ID: 8189783 [TBL] [Abstract][Full Text] [Related]
17. [Antiphospholipid antibodies and pregnancy]. Kdous M; Hachicha R; Lombroso R; Gallardo G Tunis Med; 2005 Jan; 83(1):1-5. PubMed ID: 15881713 [TBL] [Abstract][Full Text] [Related]
18. Prothrombotic mechanisms based on the impairment of fibrinolysis in the antiphospholipid syndrome. Forastiero R; Martinuzzo M Lupus; 2008 Oct; 17(10):872-7. PubMed ID: 18827051 [TBL] [Abstract][Full Text] [Related]
19. Antiphospholipid syndrome: long-time research on pathogenic mechanisms has finally lead to new therapeutic strategies. Cervera R; Espinosa G Expert Opin Ther Targets; 2010 Dec; 14(12):1279-82. PubMed ID: 21058919 [TBL] [Abstract][Full Text] [Related]
20. Evidence for heterogeneity of the obstetric antiphospholipid syndrome: thrombosis can be critical for antiphospholipid-induced pregnancy loss. Poindron V; Berat R; Knapp AM; Toti F; Zobairi F; Korganow AS; Chenard MP; Gounou C; Pasquali JL; Brisson A; Martin T J Thromb Haemost; 2011 Oct; 9(10):1937-47. PubMed ID: 21848640 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]